Skip to main content
. 2016 Feb 8;34(11):1182–1189. doi: 10.1200/JCO.2015.65.1158

Table 2.

Number of Deaths and Survivors and Death Rate at Each Time Point by Treatment

Variable 30 Days 60 Days 90 Days 6 Months
No. of deaths
 Overall 109 215 281 540
 Surgery 13 20 23 46
 5-FU + LV 76 149 200 393
 5-FU + LV plus irinotecan 9 16 17 29
 5-FU + LV plus oxaliplatin 11 30 41 72
No. of survivors
 Overall 37,356 37,223 37,133 36,825
 Surgery 2,347 2,340 2,336 2,313
 5-FU + LV 26,973 26,887 26,826 26,611
 5-FU + LV plus irinotecan 2,193 2,182 2,181 2,169
 5-FU + LV plus oxaliplatin 5,843 5,814 5,790 5,732
Death rate, %
 Overall 0.29 0.57 0.75 1.4
 Surgery 0.55 0.85 0.98 2.0
 5-FU + LV 0.28 0.55 0.74 1.5
 5-FU + LV plus irinotecan 0.41 0.73 0.77 1.3
 5-FU + LV plus oxaliplatin 0.19 0.51 0.70 1.2

Abbreviation: 5-FU + LV, fluorouracil plus leucovorin.